Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients-Reference-Cited by-同舟云学术

Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients

Published:2013-06-29 Issue:4 Volume:85 Page:392-398
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:Journal of Neurology, Neurosurgery & Psychiatry

Author:

Velasco R.,Bruna J.,Briani C.,Argyriou A. A.,Cavaletti G.,Alberti P.,Frigeni B.,Cacciavillani M.,Lonardi S.,Cortinovis D.,Cazzaniga M.,Santos C.,Kalofonos H. P.

Publisher

BMJ

Subject

Psychiatry and Mental health,Clinical Neurology,Surgery

Reference40 articles.

1. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial;Rothenberg;J Clin Oncol,2003

2. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;Andre;N Engl J Med,2004

3. Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study;Kalofonos;Ann Oncol,2005

4. Randomized Phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer;Cassidy;J Clin Oncol,2008

5. Oxaliplatin-related side effects: characteristics and management;Cassidy;Semin Oncol,2002

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-08-06

2. Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system;Frontiers in Pharmacology;2024-07-09

3. Plasma neurofilament light chain levels in chemotherapy‐induced peripheral neurotoxicity according to type of anticancer drug;European Journal of Neurology;2024-07

4. Process evaluation protocol plan for a home-based physical activity intervention versus educational intervention for persistent taxane-induced peripheral neuropathy (B-HAPI study): a randomized controlled trial;BMC Cancer;2024-06-27

5. Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study;International Journal of Clinical Oncology;2024-02-28